Epigenetics may influence the expression of numerous genes, which might contribute to autoimmune diseases. DNA methylation is mediated by DNA methyltransferases, especially DNA methyltransferase 3B (DNMT3B). Polymorphisms of the DNMT3B gene may influence DNMT3B activity on DNA methylation and increase the susceptibility to several diseases. The current study investigated the association between DNMT3B 579G>T and the risk for idiopathic thrombocytopenic purpura (ITP). The DNMT3B 579G>T polymorphisms were analyzed by PCR-RFLP. There was no significant difference in genotype and allele distribution between the ITP patient and the controls (p = 0.722 and 0.667, respectively). Similar results were observed between the 2 groups when stratified by age and disease course, including acute in childhood, chronic in childhood, acute in adult and chronic in adult. Importantly, this study showed a statistical difference in the distribution of SNP of DNMT3B between Chinese and Koreans or Americans. It is shown that the SNP of DNMT3B 579G>T may not be used on its own as a marker to predict the susceptibility to ITP in a Chinese population and that DNMT3B 579G>T promoter SNP varies from one ethnic population to another.

Yang R, Han ZC: Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update. Int J Hematol 2000;71:18–24.
Cines DB, Blanchette VS: Immune thrombocytopenic purpura. N Engl J Med 2002;346:995–1008.
Cooper N, Bussel J: The pathogenesis of immune thrombocytopaenic purpura. Br J Haematol 2006;133:364–374.
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN: Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386–2393.
Wilson CB, Makar KW, Shnyreva M, Fitzpatrick DR: DNA methylation and the expanding epigenetics of t cell lineage commitment. Semin Immunol 2005;17:105–119.
Fitzpatrick DR, Wilson CB: Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 2003;109:37–45.
Smale ST, Fisher AG: Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 2002;20:427–462.
Luczak MW, Jagodzinski PP: The role of DNA methylation in cancer development. Folia Histochem Cytobiol 2006;44:143–154.
Turek-Plewa J, Jagodzinski PP: The role of mammalian DNA methyltransferases in the regulation of gene expression. Cell Mol Biol Lett 2005;10:631–647.
Hermann A, Gowher H, Jeltsch A: Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 2004;61:2571–2587.
Clarke LE, Leitzel K, Smith J, Ali SM, Lipton A: Epidermal growth factor receptor mrna in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by rt-pcr. Int J Oncol 2003;22:425–430.
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H: Expression of DNA methyltransferases DNMT1, 3a, and 3b in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001;97:1172–1179.
Nagai M, Nakamura A, Makino R, Mitamura K: Expression of DNA (5-cytosin)-methyltransferases (DNMTs) in hepatocellular carcinomas. Hepatol Res 2003;26:186–191.
Patra SK, Patra A, Zhao H, Dahiya R: DNA methyltransferase and demethylase in human prostate cancer. Mol Carcinog 2002;33:163–171.
Saito Y, Kanai Y, Nakagawa T, Sakamoto M, Saito H, Ishii H, Hirohashi S: Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas. Int J Cancer 2003;105:527–532.
Yakushiji T, Uzawa K, Shibahara T, Noma H, Tanzawa H: Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 2003;22:1201–1207.
Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilar- dell-Tarres M: Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus. Immunology 2008;124:339–347.
Wang J, Walsh G, Liu DD, Lee JJ, Mao L: Expression of ΔDNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Cancer Res 2006;66:8361–8366.
Cebrian A, Pharoah PD, Ahmed S, Ropero S, Fraga MF, Smith PL, Conroy D, Luben R, Perkins B, Easton DF, Dunning AM, Esteller M, Ponder BA: Genetic variants in epigenetic genes and breast cancer risk. Carcinogenesis 2006;27:1661–1669.
Montgomery KG, Liu MC, Eccles DM, Campbell IG: The DNMT3B C–>T promoter polymorphism and risk of breast cancer in a British population: a case-control study. Breast Cancer Res 2004;6:R390–R394.
Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q: A novel polymorphism in human cytosine DNA-methyltransferase-3b promoter is associated with an increased risk of lung cancer. Cancer Res 2002;62:4992–4995.
Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Cho YL, Jung TH, Park JY: DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2005;26:403–409.
Tao J, Yang M, Chen Z, Huang Y, Zhao Q, Xu J, Ren H, Zhao H, Chen Z, Ren Q, Yang R: Decreased DNA methyltransferase 3a and 3b mRNA expression in peripheral blood mononuclear cells and increased plasma SAH concentration in adult patients with idiopathic thrombocytopenic purpura. J Clin Immunol 2008;28:432–439.
Hong YS, Lee HJ, You CH, Roh MS, Kwak JY, Lee MJ, Kim JY: Dnmt3b 39179gt polymorphism and the risk of adenocarcinoma of the colon in Koreans. Biochem Genet 2007;45:155–163.
Jung AY, Poole EM, Bigler J, Whitton J, Potter JD, Ulrich CM: DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 2008;17:330–338.
Deng C, Kaplan MJ, Yang J, Ray D, Zhang Z, McCune WJ, Hanash SM, Richardson BC: Decreased RAS-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum 2001;44:397–407.
Chang KP, Hao SP, Liu CT, Cheng MH, Chang YL, Lee YS, Wang TH, Tsai CN: Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. Oral Oncol 2007;43:345–351.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.